摘要
如今,中东地区有超过三千二百万的糖尿病患者,预计到2040这个数字将翻一番。与欧洲和北美形成鲜明对比,尽管流行率很高在ME糖尿病方面,有关该地区糖尿病发病率和类型的流行病学数据非常有限。青少年的成熟型糖尿病(Mody)是一种代表单基因糖尿病的亚型。2-5%的糖尿病患者。本病为常染色体显性遗传模式,以35岁以下β细胞异常为特征。到目前为止,有15种不同的MODY表单已被确认;每一个都有不同的遗传病因。MODY在1型糖尿病和2型糖尿病之间被误诊是很常见的。因此,准确的基因诊断对于个体来说是至关重要的。e治疗及改善血糖控制。新技术,如下一代测序(NGS),为筛选和识别导致MODY突变提供了极好的选择。在这场革命中我们总结了每种MODY型的主要临床和遗传特征。此外,我们还阐明了在ME地区开展的MODY研究。
关键词: 青少年的成熟型糖尿病,中东地区的单基因糖尿病,常染色体显性模式,血糖,下一代测序。
Current Molecular Medicine
Title:Maturity-Onset Diabetes of the Young: An Overview with Focus on the Middle East
Volume: 17 Issue: 8
关键词: 青少年的成熟型糖尿病,中东地区的单基因糖尿病,常染色体显性模式,血糖,下一代测序。
摘要: Today, there are more than 32 million patients with diabetes in the Middle East (ME), the number is expected to double by 2040. In contrast to Europe and North America and despite the high prevalence of diabetes in ME, epidemiological data about incident and types of diabetes in the region is very limited.
Maturity-onset diabetes of the young (MODY) is a subtype of monogenic diabetes representing 2-5% of all diabetes patients. The disease is autosomal dominant mode of inheritance characterized by β-cell malfunction below the age of 35 years. To date, there are 15 different MODY forms that have been identified; each has a distinct genetic etiology.
It is very common that MODY is misdiagnosed between with type 1 or type 2 diabetes. Hence, accurate genetic diagnosis is crucial to individualize the treatment and to improve glycaemia control. New technologies such as next-generation sequencing (NGS) offer an excellent alternative to screen and identify causative MODY mutations. In this review, we summarize the main clinical and genetic characteristics for each MODY form. In addition, we shed light on MODY studies that have been executed in the ME region.
Export Options
About this article
Cite this article as:
Maturity-Onset Diabetes of the Young: An Overview with Focus on the Middle East, Current Molecular Medicine 2017; 17 (8) . https://dx.doi.org/10.2174/1566524018666180222121158
DOI https://dx.doi.org/10.2174/1566524018666180222121158 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of β-glucan from Aureobasidium pullulans in a Streptozotocininduced Rat Diabetes Model
Current Nutrition & Food Science Clozapine Safety, 40 Years Later
Current Drug Safety Underlying Pathways for Interferon Risk to Type II Diabetes Mellitus
Current Diabetes Reviews A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and Augmentation
Current Medicinal Chemistry Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Current Diabetes Reviews Self-management of Diabetes in Children and Young Adults Using Technology and Smartphone Applications
Current Diabetes Reviews Insulin Therapy: Going The "Smarter" Way
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a<sup>-/-</sup> Model
Current Pharmaceutical Design Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders
Current Genomics Why Not to Use the Handgrip Test in the Assessment of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes Mellitus?
Current Vascular Pharmacology Computer-Based versus Paper-Based Insulin Infusion Algorithms in Diabetic Ketoacidosis
Current Diabetes Reviews Cystic Fibrosis Related Diabetes Mellitus - Diagnostic and Management Challenges
Current Diabetes Reviews Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
Current Medicinal Chemistry Risk Factors for Suicide – An Alternative View
CNS & Neurological Disorders - Drug Targets Type 1 Diabetes in Young Adulthood
Current Diabetes Reviews Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies
Current Drug Metabolism Antifungal Therapy Used in Central Nervous System Fungal Infections
Central Nervous System Agents in Medicinal Chemistry Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia
Current Vascular Pharmacology Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms
Current Genomics